Investigating the candidacy of the serotype specific rhamnan polysaccharide based glycoconjugates to prevent disease caused by the dental pathogen Streptococcus mutans

From National Research Council Canada

DOIResolve DOI: https://doi.org/10.1007/s10719-017-9798-z
AuthorSearch for: 1; Search for: 1; Search for: 1; Search for: 1; Search for: 1; Search for: 1; Search for: 1; Search for: 1
Affiliation
  1. National Research Council of Canada. Human Health Therapeutics
FormatText, Article
SubjectStreptococcus mutans; conjugate vaccine; serotype polysaccharide; rhamnan
Abstract
Publication date
PublisherSpringer
In
LanguageEnglish
Peer reviewedYes
NPARC number23002488
Export citationExport as RIS
Report a correctionReport a correction (opens in a new tab)
Record identifierb98ce473-3e38-48e0-997b-cfd7c203c31e
Record created2017-11-16
Record modified2020-03-16
Date modified: